Physician profile
Reenaben Patel
NPI 1285049221
$2,091.83
in general payments reported to CMS, 2019-2025
24 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $680 · 2023: $479 · 2024: $472 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $459.26 | 2022-2025 | Mounjaro, Trulicity, Zepbound |
| Abbvie INC. | $172.91 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $160.32 | 2022-2023 | |
| Glaxosmithkline, LLC. | $157.40 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $134.59 | 2022-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.09 | 2023-2025 | Jardiance, Tradjenta |
| Lundbeck LLC | $126.22 | 2024 | Rexulti |
| Intra-Sana Laboratories | $115.59 | 2024-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Astellas Pharma US INC | $97.03 | 2022 | |
| Amgen INC. | $81.83 | 2022-2023 | Repatha, Otezla |
| Exact Sciences Corporation | $79.45 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $43.40 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $43.14 | 2024 | Rexulti |
| Chiesi USA, INC. | $40.29 | 2024-2025 | Elfabrio |
| Biohaven Pharmaceutical Holding Company LTD. | $37.44 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $32.57 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Janssen Pharmaceuticals, INC | $29.97 | 2022 | |
| Genzyme Corporation | $29.33 | 2023 | |
| Merck Sharp & Dohme LLC | $24.74 | 2022 | |
| Eisai INC. | $23.07 | 2022 | |
| Abbott Laboratories | $22.76 | 2025 | Freestyle Libre 3 |
| Boston Scientific Corporation | $17.49 | 2022 | |
| Inogen, INC. | $15.94 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Edwards Lifesciences Corporation | $15.00 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reenaben Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.